MN-221-CL-007: A phase II, randomized, double-blinded, placebo-controlled study to evaluate the safety and efficacy of MN-221 when administered intravenously as an adjunct to standard therapy to adults with an acute exacerbation of asthma,
Role: Investigator,
MediciNova, Inc.,
(07/2011 - 07/2012)
Status: Completed
Internal
Comparative Analysis of Answers to Patient Care Questions: An AI Chatbot (ChatGPT) vs. Physician,
Role: Investigator,
LLU Dept. of Medicine,
(06/2024)
Status: Approved
Teaching endotracheal intubation using iPad and sports performance analysis software,
Role: Investigator,
LLU Dept. of Emergency Medicine,
(09/2018 - 09/2019)
Status: Completed